These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 12480357
1. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Suckfüll M, Hearing Loss Study Group. Lancet; 2002 Dec 07; 360(9348):1811-7. PubMed ID: 12480357 [Abstract] [Full Text] [Related]
2. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]. Suckfüll M, Seidel D, Thiery J, Mazurek B, Jaehne M, Gronemeyer J, Reichel O, Sasama J, Kichigina S, Möller M, Beil FU, Schrameyer-Wernecke A, Kassner U, Koch M, Jaeger B, Osterkorn K, Osterkorn D. Z Kardiol; 2003 Dec 07; 92(Suppl 3):III59-63. PubMed ID: 14663604 [Abstract] [Full Text] [Related]
3. Treatment with HELP-apheresis in patients suffering from sudden sensorineural hearing loss: a prospective, randomized, controlled study. Bianchin G, Russi G, Romano N, Fioravanti P. Laryngoscope; 2010 Apr 07; 120(4):800-7. PubMed ID: 20213795 [Abstract] [Full Text] [Related]
4. Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients. Heigl F, Hettich R, Suckfuell M, Luebbers CW, Osterkorn D, Osterkorn K, Canis M. Atheroscler Suppl; 2009 Dec 29; 10(5):95-101. PubMed ID: 20129384 [Abstract] [Full Text] [Related]
8. Rheopheresis for sudden sensorineural hearing loss. Klingel R, Heibges A, Uygun-Kiehne S, Fassbender C, Mösges R. Atheroscler Suppl; 2009 Dec 29; 10(5):102-6. PubMed ID: 20129385 [Abstract] [Full Text] [Related]
9. Clinical utility of LDL-apheresis in the treatment of sudden hearing loss: a prospective, randomized study. Suckfüll M, Thiery J, Schorn K, Kastenbauer E, Seidel D. Acta Otolaryngol; 1999 Dec 29; 119(7):763-6. PubMed ID: 10687932 [Abstract] [Full Text] [Related]
12. Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss. Canis M, Heigl F, Suckfuell M. Clin Res Cardiol Suppl; 2012 Jun 29; 7(Suppl 1):36-40. PubMed ID: 22528132 [Abstract] [Full Text] [Related]
14. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)]. Blessing F, Jaeger BR, Oberhoffer M, Reichart B, Seidel D. Z Kardiol; 2003 Jun 29; 92(Suppl 3):III42-7. PubMed ID: 14663601 [Abstract] [Full Text] [Related]
15. [Hypercholesteremia and hyperfibrinogenemia in sudden deafness]. Suckfüll M, Thiery J, Wimmer C, Mees K, Schorn K. Laryngorhinootologie; 1997 Aug 29; 76(8):453-7. PubMed ID: 9376027 [Abstract] [Full Text] [Related]
16. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Laryngoscope; 2007 Jan 29; 117(1):3-15. PubMed ID: 17202923 [Abstract] [Full Text] [Related]
17. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness]. Walch C, Anderhuber W, Walzl M. Laryngorhinootologie; 1996 Nov 29; 75(11):641-5. PubMed ID: 9063830 [Abstract] [Full Text] [Related]